How can patient preferences be used and communicated in the regulatory evaluation of medicinal products? Findings and recommendations from IMI PREFER and call to action

por Janssens, Rosanne, Barbier, Liese, Muller, Mireille, Cleemput, Irina, Stoeckert, Isabelle, Whichello, Chiara, Levitan, Bennett, Hammad, Tarek A., Girvalaki, Charis, Ventura, Juan-Jose, Bywall, Karin Schölin, Pinto, Cathy Anne, Schoefs, Elise, Katz, Eva G., Kihlbom, Ulrik, Huys, Isabelle
Publicado 2023